CD40L Recombinant Antibody, FITC Conjugated
Product Specifications
Background
Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL-4. Involved in immunoglobulin class switching. Release of soluble CD40L from platelets is partially regulated by GP IIb/IIIa, actin polymerization, and an matrix metalloproteinases (MMP) inhibitor-sensitive pathway.
Synonyms
CD40 ligand; CD40-L; T-cell antigen Gp39; TNF-related activation protein; TRAP; CD154; CD40 ligand, membrane form; CD40 ligand, soluble form; CD40LG; CD40L; TNFSF5; TRAP.
Gene ID
959
Swiss Prot
P29965
Cellular Locus
Secreted, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse
Target
CD40L
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human CD40L
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
959
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15082118 1 Vial
Lentiviral human CERS6 shRNA (UAS) - Lentiviral human CERS6 shRNA (UAS, iRFP) (25)
Ask
View Details